Scott Worrell, MD
Sports Medicine · Hagerstown, MDNPI 1598725442
Payments from drug & device makers
What this record shows
This record is dominated by education: $1,200 of the $1,998 with a category attached, or 60.1%. Supreme Orthopedic Systems, LLC accounts for 60.1% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2022 at $1,200 and has fallen 96.8% since, to $38 in 2025.
Across 25 payments — averaging $79.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supreme Orthopedic Systems, LLC$1K
- Linvatec Corporation$163
- Zimmer Biomet$129
- Dynasplint Systems Inc.$106
- Ferring Pharmaceuticals Inc.$78
- Arthrex$52
- plus $270 from 11 others
What the payments were for
- Food & beverage$79840%
- Education$1,20060%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supreme Orthopedic Systems, LLC | 1 | $1,200 |
| Linvatec Corporation | 2 | $163 |
| Zimmer Biomet | 3 | $129 |
| Dynasplint Systems Inc. | 1 | $106 |
| Ferring Pharmaceuticals Inc. | 4 | $78 |
| Arthrex | 1 | $52 |
| Amgen(2 entities) | 3 | $46 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $41 |
| Stryker | 1 | $37 |
| ERMI LLC | 1 | $26 |
| Pacira Therapeutics, Inc. | 1 | $25 |
| Abbott | 1 | $20 |
| Solventum Corporation | 1 | $19 |
| Medtronic | 1 | $17 |
| Theragen, Inc. | 1 | $14 |
| Fidia Pharma USA Inc. | 1 | $12 |
| Smith+Nephew | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,998 in reported general payments places this provider in the 55th percentile of 111 sports medicine providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium ErDiclofenac Sodium | 17 | $461 |
| Gabapentin | 31 | $233 |
| Tizanidine Hcl | 32 | $230 |
| Meloxicam | 79 | $190 |
| Celecoxib | 19 | $173 |
| Ketorolac Tromethamine | 13 | $134 |
| Ibuprofen | 11 | $128 |
| Methocarbamol | 14 | $120 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $100 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Hagerstown
- Paul MyersHagerstown$34K
- Shahab SiddiquiHagerstown$4K
- Garrett LynchAnnapolis$1.4M
- Raymond ThalBethesda$779K
- Jason ScoppSalisbury$637K
- John ChristoforettiBethesda$418K
- Jonas RudzkiChevy Chase$386K
- Matthew LevineFrederick$364K
- Abdulaziz AhmedBaltimore$85K
- Taylor WileySalisbury$53K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.